BioSpace News Archive

Within Our Backyard: Finding Solutions to Overcome Research Resistance

For most biopharma sponsors, the crux of their challenge is how to identify an adequate number of evaluable patients to sufficiently power their late phase clinical research.

November 2, 2017

·

4 min read

·

Mary Costello, BioSpace.com Contributor

Business

Amgen, Novartis Rev Up for New Alzheimer’s Study

Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute to launch a new clinical trial in ALZ’s.

November 2, 2017

·

2 min read

·

Mark Terry

Deals

Shark Tank Billionaire Mark Cuban Invests in Tiny Bay Area Biotech Perlara

November 2, 2017

·

2 min read

·

Mark Terry

Business

Schrodinger Appoints Dov Goldstein, M.D., as CFO

Dr. Goldstein brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector.

November 2, 2017

·

3 min read

Business

Sectra Enters the Philippines by Signing Medical Imaging Distribution Agreement With Medical One

“This distribution agreement with Medical One will enable us to address these demands by combining their market-specific expertise with our extensive experience in delivering scalable solutions that cover multiple enterprises in large geographic areas--within teleradiology and telepathology specifically.”

November 2, 2017

·

3 min read

Drug Development

Betagenon/Baltic Bio Announces Positive Results From a 28-day Phase IIa Trial of the First-in-class AMPK Activator O304 in Type 2 Diabetics

Review of the initial data showed that a number of patients who were included based on HbA1c at screening, had FPG below 7 mM or above 13.3 mM at day 1, and that the data analysis of FPG required a post hoc analysis plan.

November 2, 2017

·

4 min read

Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

The grant of up to approximately £400,000, with additional funding from MiNA and LGC LINK, will support a two-year research project.

November 2, 2017

·

3 min read

Drug Development

Ionis Presents New Data From NEURO-TTR Study at European ATTR Amyloidosis Meeting

The NEURO-TTR study met both co-primary endpoints, the Norfolk QoL-DN, a validated instrument for physician-assessed quality of life, and mNIS+7, a validated instrument for evaluating hATTR disease severity.

November 2, 2017

·

10 min read

Business

BioLife Solutions to Report Third Quarter 2017 Financial Results and Provide Business Update on November 9, 2017

Management will provide an overview of the Company’s financial results and a general business update.

November 2, 2017

·

1 min read

Pharm Country

Teleflex Announces Quarterly Dividend

The dividend is payable December 15, 2017 to shareholders of record at the close of business on November 15, 2017.

November 2, 2017

·

1 min read